Hospital General Universitario Gregorio Marañon   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Madrid Spain (1567)

Organization Overview

First Clinical Trial
2005
NCT01549782
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Antonio Calles Blanco | Begoña Quintana Villamandos | Blanco, Dr Antonio Calles MD | Francisco Andres de la Gala | Gregorio Marañón Hospital | Hospital General Universitario Gregorio Marañón | Hospital General Universitario Gregorio Maranon | Hospital General Universitario Gregorio Marañon | Hospital General Universitario Gregorio Marañón | HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARANON, MADRID | Hospital General Universitario Gregorio Marañón. Pediatric Intensive Care Unit. | Hospital Gregorio Maranon | Hospital Gregorio Marañon | Hospital Universitario Gregorio Marañón | Luis Puente Maestu | Mª del Carmen Lobo Rodríguez | Rafael Correa-Rocha

Active Ingredients

Drugs in Phase 4 Trials (22)

adalimumab (humira) (1 trial)

amiodarone (cordarone) (2 trials)

amlodipine (norvasc) (1 trial)

autologous dendritic cells (1 trial)

capecitabine (xeloda) (1 trial)

dapagliflozin (farxiga) (1 trial)

desflurane (suprane) (1 trial)

gemcitabine (gemzar) (1 trial)

haloperidol (haldol) (1 trial)

human fibrin (1 trial)

lidocaine (xylocaine) (1 trial)

lisinopril (zestril) (1 trial)

meperidine (demerol) (1 trial)

prilocaine (citanest) (1 trial)

procainamide (pronestyl) (1 trial)

propofol (diprivan) (2 trials)

remifentanil (ultiva) (2 trials)

sevoflurane (ultane) (2 trials)

sildenafil (viagra) (1 trial)

somatropin (protropin) (1 trial)

umeclidinium (incruse ellipta) (1 trial)

vilanterol (Anoro Elipta) (1 trial)

Drugs in Phase 3 Trials (8)

acetylsalicylic acid (aspirin) (1 trial)

adenosine (Adenocard) (1 trial)

albuterol (proventil) (1 trial)

beclomethasone (vanceril) (1 trial)

cyclosporine (sandimmune) (1 trial)

evolocumab (repatha) (1 trial)

mycophenolate (myfortic) (1 trial)

prednisone (meticorten) (1 trial)

Drugs in Phase 2 Trials (21)

3bnc117 (1 trial)

abemaciclib (verzenio) (1 trial)

aflibercept (zaltrap) (1 trial)

allogeneic adipose derived mesenchymal stem cell (2 trials)

arbaclofen (1 trial)

autologous mesenchymal stem cells (1 trial)

autologous thytreg (1 trial)

binimetinib (mektovi) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

danegaptide (1 trial)

doxorubicin (Doxil) (1 trial)

encorafenib (braftovi) (1 trial)

fluorouracil (efudex) (1 trial)

irinotecan (Camptosar) (1 trial)

letrozole (femara) (1 trial)

leucovorin (1 trial)

lurbinectedin (1 trial)

omalizumab (xolair) (1 trial)

pembrolizumab (keytruda) (1 trial)

taxane (1 trial)

trabectedin (yondelis) (1 trial)

Drugs in Other Trials (10)

carboplatin (paraplatin) (1 trial)

docetaxel (taxotere) (1 trial)

ethanol (1 trial)

fructo-oligosaccharide (1 trial)

heparin (liquaemin) (1 trial)

icosapent ethyl (vascepa) (1 trial)

indocyanine green (ic-green) (1 trial)

inulin (1 trial)

maltodextrin (1 trial)

sotalol (betapace) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 3)

Acute Lung Injury (Phase 4)

Anastomotic Leak (Phase 4)

Asthma (Phase 3)

Autism Spectrum Disorder (Phase 2)

Breast Neoplasms (Phase 2)

Cholangiocarcinoma (Phase 4)

Chronic Disease (Phase 2)

Colorectal Neoplasms (Phase 2)

Crohn Disease (Phase 4)

Heart Diseases (Phase 4)

Heart Failure (Phase 4)

Heart Valve Diseases (Phase 4)

HIV Infections (Phase 4)

Hypercholesterolemia (Phase 3)

Hypertension (Phase 4)

Hypertension, Pulmonary (Phase 4)

Infarction (Phase 3)

Inflammation (Phase 4)

Kidney Diseases (Phase 3)

Klatskin Tumor (Phase 4)

Labor Pain (Phase 4)

Lung Diseases (Phase 4)

Lung Injury (Phase 4)

Lupus Nephritis (Phase 3)

Melanoma (Phase 2)

Myocardial Infarction (Phase 3)

Neoplasm Metastasis (Phase 2)

Nephritis (Phase 3)

Paralysis (Phase 2)

Pneumonia (Phase 4)

Postoperative Complications (Phase 4)

Proteinuria (Phase 4)

Renal Insufficiency (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Respiratory Aspiration (Phase 4)

Respiratory Distress Syndrome (Phase 2)

Respiratory Distress Syndrome, Newborn (Phase 2)

Rotator Cuff Injuries (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Tachycardia (Phase 4)

Tachycardia, Ventricular (Phase 4)

Urticaria (Phase 2)

Vocal Cord Paralysis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 38
  • # of Trial APIs: 61